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Mechanisms of autonomic nervous system dysfunction in uremia.
Autonomic nervous system (ANS) function was evaluated in 60 normal
subjects, 21 predialysis patients, 16 dialysis patients, and 15 patients
with chronic illnesses and normal renal function by Valsalva ratio,
hand-grip exercise, and response to orthostasis. Blood levels of norepi-
nephrine (NE) and the response to NE infusion were also evaluated.
Valsalva ratio was normal in patients with chronic illness and signifi-
cantly reduced (P < 0.01) in both dialysis and predialysis patients; this
abnormality was more marked in the latter. During upright posture,
mean blood pressure (MBP) decreased significantly in predialysis but
not in dialysis patients. During hand-grip exercise, the increment of
heart rate was significantly reduced (P < 0.01) in the patients with
uremia and this abnormality appeared related to the disturbance in
Valsalva ratio. Plasma NE in predialysis (35 3.6 ng/dl) was higher (P
<0.01) than it was in dialysis patients (24 3 ng/dl), normal subjects
(21 1 ngldl) and in those with chronic illness (21 3 ngldl). The
magnitude of rise in plasma NE in response to orthostasis was greater
(P < 0.01) in predialysis (60 7 ng/dl) than it was in dialysis patients (30
5 ng/dl) and normal subjects (28 2 ng/dl). NE infusion produced
smaller (P < 0.05) changes in MBP and heart rate in predialysis than it
did in dialysis patients and in normals. These data indicate that
disturbances of ANS function are common in uremia and that they are
more extensive in predialysis than in dialysis patients. Taken together,
the results are consistent with the notion that the mechanisms for these
derangements are multifactonal. Reduced end-organ response to NE
appears to be a major factor underlying these abnormalities in predialy-
sis patients; derangements in the parasympathetic nervous system and!
or disturbances in cardiac function may also be involved.
Mécanismes du dysfonctionnement du système nerveux autonome au
cours de I'uremie. Le fonctionnement du système nerveux autonome
(ANS) a étè évalué chez 60 sujets normaux, 21 malades avant l'institu-
tion de Ia dialyse, 16 malades en dialyse et 15 malades atteints
d'affections chroniques mais avec une fonction rénale normale, par le
rapport de Valsalva, l'epreuve du serrement de main et Ia réponse a
l'orthostatisme. Les concentrations plasmatiques de norépinephrine
(NE) et Ia réponse a Ia perfusion de NE ont aussi été évaluées. Le
rapport de Valsalva Ctait normal chez les malades atteints d'affections
chroniques et significativement réduit (P < 0,01) chez les malades
dialyses et avant Ia dialyse. L'anomalie était plus importante chez ces
derniers. Au cours de Ia position debout, Ia pression sanguine moyenne
(MBP) a diminué de facon significative chez les malades avant Ia
dialyse, mais pas chez les malades dialyses. Au cours de l'épreuve du
serrement de main l'augmentation du rythme cardiaque a été significa-
tivement diminuée (P < 0,01) chez les malades urémiques et cette
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anomalie paraIt en rapport avec Ia modification du rapport de Valsalva.
La NE plasmatique était plus élevée (P < 0,01) chez les malades avant
Ia phase de dialyse (35 3,6ng!dl) que chez les malades dialyses (24
3 ng/dl), les sujets normaux (21 1 ng/dl) et les sujets atteints
d'affections chroniques (21 3 ng/dl). L'amplitude de l'augmentation
de NE du plasma en réponse a l'orthostatisme était plus importante (P
< 0,01) chez les malades avant dialyse (60 7 ng/dl) que chez les
malades dialyses (30 5 ng/dl) et les sujets normaux (28 2 ng/dl). La
perfusion de NE a produit des modifications plus faibles (P < 0,05) de
MBP et du rythme cardiaque chez les malades avant dialyse que chez
les malades dialyses et les sujets normaux. Ces résultats indiquent que
les dCsordres de fonctionnement de ANS sont frequents dans l'urémie
et qu'ils sont plus importants chez les malades a Ia phase prédialytique
que chez les malades dialyses. Dans leur ensemble ces rCsultats sont en
accord avec Ia notion selon laquelle les mécanismes de ces désordres
sont multifonctionnels. La diminution de Ia réponse a NE de l'organe
cible parait ètre un facteur majeur de ces anomalies chez les malades
avant Ia dialyse. Des alterations du système parasympathique et/ou des
désordres de Ia fonction cardiaque pourraient aussi ètre impliquCs.
Several abnormalities of autonomic nervous system (ANS)
function have been noted in patients with end-stage renal
failure, and these include defective function of sweat glands [1,
21, abnormal response to the Valsalva maneuver 13, 4], reduced
baroreceptor sensitivity [5, 6], reduced elevation in blood
pressure in response to sustained hand-grip exercise [4], and
nonvolume responsive hypotension during hemodialysis 171.
The pathogenesis of these disturbances and the localization of
the lesion responsible for them along the baroreceptor reflex arc
are, as yet, not clear, however.
Some investigators [8] postulated, on the basis of an abnor-
mal amyl nitrate inhalation test (a functional index of the entire
baroreceptor reflex arc) and of a normal cold pressor test (a
proposed index of the efferent pathway) that the lesion may
reside in the baroreceptors. Others, have found, on the other
hand, that plasma norepinephrine (NE) levels are elevated in
patients with renal failure. The association of elevated levels of
NE and ANS dysfunction could suggest end-organ resistance to
the action of NE. In addition, patients with advanced renal
failure have marked anemia and suffer from a state of chronic
illness; the role of these factors in the genesis of ANS dysfunc-
tion in uremia have not been examined. The present study was
undertaken in 138 subjects in an attempt to investigate the
factors responsible for the genesis of the dysfunction of the
ANS in patients with advanced chronic renal failure.
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Methods
A total of 112 subjects, including 60 normal volunteers, 37
patients with chronic uremia, and 15 patients with chronic
illness but normal renal function, were studied for evaluation of
ANS function. Patients with diabetes mellitus, congestive heart
failure, and those receiving medication that may affect the
autonomic nervous system were excluded from the study.
Other studies were carried out in an additional 10 patients with
essential hypertension for the evaluation of pressor response to
NE infusion and in an additional 16 patients on maintenance
hemodialysis for the examination of the effect of dialysis
procedure on blood levels of catecholamines as detailed below.
The nature of the research was explained to all participants, and
an informed consent was obtained prior to the study.
Among the normal persons, there were 41 males and 19
females, with their ages ranging between 18 and 52 (35.0 1)
years. They were selected from the medical and the paramedi-
cal personnel of the Los Angeles County-University of South-
ern California Medical Center. The 37 uremic patients were
made up of two groups: (1) 21 patients with creatinine clear-
ances of less than 8 mi/mm and who were not treated with
dialysis (referred to hereafter as "predialysis" patients).
Among them were 12 males and 9 females (age range, 19 to 62
[40 3] years). These patients were ambulatory before admis-
sion to the hospital for evaluation and preparation for dialysis.
(2) The other group was 16 patients treated with chronic
maintenance hemodialysis for 0.5 to 10 (4.5 0.9) years. They
received 4 to S hours of hemodialysis three times a week.
Among them were 11 males and 5 females (age range, 21 to 60
[38 31 years). All patients were at home and came to the
Center three times a week for dialysis. The studies in the
patients were carried out on the day when they did not receive
dialysis therapy.
The causes of the renal failure in the 37 patients were chronic
glomerulonephritis in 11, malignant hypertension in 7, obstruc-
tive uropathy in 4, pyelonephritis in 3, polycystic kidney
disease in 2, interstitial nephritis in 1, medullary cystic disease
in I, and the cause was unknown in 8 patients. All patients with
chronic uremia received a diet containing 40 to 60 g of protein
and 100 mEq of sodium per day, and all antihypertensive
medications were discontinued at least 2 weeks prior to the
study. The concentrations of various compounds in the blood of
predialysis and dialysis patients were: urea, 118 11 and 88 9
mgldl, P < 0.05; creatinine, 13.7 1.0 and 17.9 1.2 mg/dl, P
<0.02; sodium 136 2 and 139 1 mEqfliter, NS; potassium,
4.6 0.3 and 5.3 0.3 mEq/liter, NS; calcium, 8.0 0.3 and
8.9 0.3 mg/dl, P < 0.05; phosphorus, 5.9 0.4 and 5.0 0.5
mEq/iiter, NS; magnesium, 2.5 0.2 and 2.7 0.2 mg/dI, NS,
respectively.
The 15 patients with chronic illness and normal renal function
were all males, and their ages ranged between 22 and 63 (43 3)
years. Eleven were recruited from the medical outpatient clinic,
and 4 were at the hospital at the time of the study. Creatinine
clearance was 85 to 160 (113 57) mi/mm, and hematocrit was
19.0 to 44.7% (39.6 1.9%). Four patients had rheumatoid
arthritis, 5 Hodgkin's disease, 2 chronic obstructive pulmonary
disease, I sarcoidosis, I gout, 1 scleromyxedema, and I chronic
peptic ulcer.
All normal subjects and those with chronic illness were asked
to obtain complete urine collection during the 24 hours preced-
ing the study for the measurements of sodium excretion in order
to judge their sodium intake. Both the normal subjects and the
patients were asked to fast overnight and to avoid coffee, tea,
coca-cola, chocolate, and smoking for at least 12 hours before
the study. In the morning of the study, the subjects remained in
the supine position for 1 hour and were connected to an
electrocardiograph. Thirty minutes before the start of the study,
a needle connected to a heparin lock was inserted into a forearm
vein. Blood pressure and heart rate were measured, and blood
samples were obtained for the determination of plasma norepi-
nephrine (NE), epinephrine (E) and plasma renin activity (PRA)
after resting supine for 1 hour. While still in the supine position
and after instruction on the use of the hand-grip dynamometer,
the subjects gripped the instrument maximally with their hand
for a few seconds. The highest value of three grip contractions
was taken as the maximum voluntary contraction (MVC).
Hand-grip was then maintained steadily at 30% MVC to the
end-point of tiring. Heart rate and blood pressure were mea-
sured, and blood samples were obtained at the end-point of the
sustained hand grip. Fifteen minutes later and while the sub-
jects were still supine, they performed the Vaisaiva maneuver
at an expiratory pressure of 40 mm Hg for 12 sec while blowing
through a mouthpiece connected to a mercury manometer. The
Valsalva maneuver was repeated three times. Heart rate was
continuously recorded throughout the maneuver and for 60 sec
after its completion. The heart rate response to the Valsalva
maneuver was expressed as the Vaisalva ratio [9]. This is
defined as the ratio between the longest R-R interval (msec)
during the release phase and the shortest R-R interval during
the strain phase of the maneuver. The value selected was the
best of the three attempts. The subjects were asked not to take
deep inspiration before the Valsalva maneuver because we
found that the Valsalva ratio was significantly (P < 0.01) lower
when the maneuver is performed following a deep inspiration
(1.77 0.05) than during normal respiration (1.99 0.06).
The effects of orthostasis were examined 15 mm after the
Valsalva maneuver. Blood pressure, heart rate, NE, PE, and
PRA were measured after 10 mm of passive standing and after
an additional 50 mm of ambulation.
To determine the vascular responsiveness to NE, we infused
the agonist into 5 of the predialysis and 6 of the dialysis
patients, 10 normal subjects, and 10 patients with essential
hypertension. The subjects were kept resting in the supine
position for 1 hour, and an indwelling i.v. catheter was inserted
into a forearm vein at least 30 mm before starting the NE
infusion. L-Norepinephrine (Levophed bitartrate; Winthrop
Laboratory, New York) was infused at a rate delivering increas-
ing amounts of 20, 50, and 100 nglkg/min with each rate given
for 10 mm. Blood pressure and heart rate were measured before
and at the end of each rate of the infusion.
The effects of a standard 4-hour hemodialysis on blood
pressure, heart rate, plasma catecholamine, and PRA were
examined in an additional 16 patients. This group included 10
males and 6 females whose ages ranged between 23 and 54(36
3) years.
In all studies, blood pressure was measured with an automat-
ic recorder (Physiometric SRII, Sphygmetrics, Woodland Hills,
California), and each data point is the average of three consecu-
tive measurements. Mean blood pressure was calculated as the
sum of diastolic blood pressure and one-third of pulse pressure.
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Fig. 1. Valsalva ratio, that is, the ratio between the longest RR interval
during the release phase and the shortest RR interval during the strain
phase of the Valsalva maneuver, in 60 normal subjects, 21 predialysis
patients, 16 patients on maintenance hemodialysis, and 15 patients with
chronic illnesses but with normal renal function. The brackets denote
the means SEM.
Heart rate was determined from electrocardiographic tracings.
Plasma renin activity (PRA) was measured by the radio-
immunoassay method of Sealey, Gerten-Banes, and Laragh
[10], with the antiserum provided by Endocrine Sciences (Tar-
zana, California), the '251-angiotensin I (5I-AI) from New
England Nuclear (Boston, Massachusetts), and the A! standard
provided by Cal Biomed (San Diego, California). The interassay
coefficient of variability for PRA was 7.3% (for 40 consecutive
determinations).
Plasma catecholamines were measured in duplicate by the
radioenzymatic method of DaPrada and Zurcher [11]; the
enzyme catechol-o-methyl transferase was prepared according
to the method of Axeirod and Tomchick [12], and 3H-methyl-s-
adenosine-methionine (New England Nuclear, Boston, Massa-
chusetts) was used as a methyl donor. The sensitivity of this
method is 1 pg for NE and E. This method is highly specific.
Among physiologic substances, only epinin and 3-4 dihydroxy-
phenyl-glycol showed minimal interference. Mean coefficient of
intraassay and control plasma variations in 78 unselected con-
secutive determinations with this method were 5.1% and 12.1%
for PNE, 5.7 and 10.1% for PE. Sodium and potassium were
determined by flame photometry (Instrumentation Labora-
tories) and creatinine by Technicon Autoanalyzer. The statisti-
cal evaluations of the data were made by one-way analysis of
variance (Anova) for comparison between means, by the Tu-
key-HSD multiple comparisons, by unpaired and paired Stu-
dent's t test and by linear regression analysis. Values are
expressed as the means SEM.
Results
The values of the Valsalva ratio in all subjects are given in
Fig. 1. The Valsalva ratio was significantly lower (P < 0.01) in
both the predialysis (1.51 SEM 0.08) and dialysis patients (1.62
0.09) than control subjects (2.10 0.05) and those with
chronic illness (2.00 0.13). The ratio was not different among
the predialysis and the dialysis patients. Even though there was
considerable overlap between groups, almost half of the predi-
Time, sec
Fig. 2. Heart rate before and during the Valsalva maneuver in normal
subjects and predialysis and dialysis patients. During the release phase,
heart rate was significantly lower (P < 0.01) in normal subjects than it
was in the two groups of uremic patients, and it was lower in dialysis (P
< 0.05) than in predialysis patients. Data are presented as means
SEM.
alysis (52%) and of the dialysis (44%) patients had values of
Valsalva ratio lower than the lowest value seen in normal
subjects or in those with chronic illness. The difference in the
Valsalva ratio was mainly due to significantly different falls in
pulse rate (as determined by RR intervals) during the release
phase of the Valsalva maneuver (Fig. 2). The highest heart rate
achieved during the strain phase was not different between the
three groups; although the change in heart rate from baseline
values was smaller in the uremic patients. During the release
phase, the lowest heart rate was 57 1 beats/mm in the normal
subjects, 80 4 beats/mm in the predialysis (P < 0.01) and 68
4 beats/mm in the dialysis patients (P < 0.01). The values were
significantly lower (P < 0.05) in dialysis than they were in
predialysis patients.
To determine whether there is a relationship between the
abnormality in the Valsalva ratio and the anemia of uremia, we
compared the hematocrit of the patients with overtly low
Valsalva ratio with those who had ratio within the normal
range. Predialysis patients with Valsalva ratio of 1.25 0.04
had hematocrits of 15.8 to 37.3% (22.5 2.6%), and those with
Valsalva ratio of 1.80 0.11 had hematocrits of 18.8 to 29.1%
(22.8 1.5%). Among the dialysis patients, the hematocrit was
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16.8 to 32.9% (23.9 2.4%) with a Valsalva ratio of 1.31 0.05
and 19.4 to 38.8% (24.9 2.5%) with a Valsalva ratio of 1.87
0.10. Furthermore, there was no significant correlation between
the individual values of the Valsalva ratio and the hematocrit
for the entire uremic population.
There was no correlation between the mean blood pressure
(BP) and the Valsalva ratio. Among the predialysis patients, 8
had a normal mean BP (84 4 mm Hg) with a Valsalva ratio of
1.54 0.17 and 13 were hypertensive (113 5 mm Hg) with a
Valsalva ratio of 1.50 0.08. Similarly, the Valsalva ratio in the
10 normotensive (88 4 mm Hg) dialysis patients was 1.67
0.11 and 1.53 0.18 in the 6 hypertensive (108 2 mm Hg)
ones. Finally, half of the uremic patients who had overtly low
Valsalva ratio were hypertensive.
During hand-grip exercise, mean BP and heart rate increased
significantly (P < 0.01, paired analysis) in all four groups of
patients studied, but the magnitude of the changes between the
different groups was different (Table 1). The increment in blood
pressure in normal subjects (28 1 mm Hg) was significantly (P
< 0.01) higher than the predialysis (15 3 mm Hg) and the
dialysis (21 2 mm Hg) patients but not different from those
with chronic illness (25 3 mm Hg). In 7 of 20(35%) predialysis
patients and in 2 of 16 (13%) dialysis patients, the change in
blood pressure was lower than the lowest value observed in
normal subjects (Fig. 3). The increment in heart rate in normal
subjects (21 1 beats/mm) was significantly higher (P < 0.01)
than predialysis (11 2 beats/mm) and dialysis (10 2 beats!
mm) patients and those with chronic illness (13 2 beats/mm).
In 16 of 36 (44%) uremic patients, the increment in heart rate
was lower than the lowest value observed in normal subjects
(Fig. 4). Only in 4 of 15 patients (27%) with chronic illness was
the change in heart rate below the normal range. It is of interest
that 8 of 11 predialysis (73%) and 5 of 7 dialysis (71%) patients
who had low Valsalva ratio also had an abnormal heart rate
response to the hand-grip exercise.
The values for mean BP, heart rate, PNE, E, and PRA during
the supine position and the effect of orthostatic stress on these
parameters in all subjects are given in Table 1.
The mean BP in predialysis (100 4 mm Hg) and dialysis
patients (95 4 mm Hg) was significantly greater (P < 0.01)
than it was in controls (81 1 mm Hg). The heart rate in
predialysis (80 3 beats/mm) and dialysis patients (79 3
beats/mm) was also significantly higher (P <0.01) than it was in
controls (64 1 beats/mm) or in those with chronic illness (67
2 beats/mm). The concentrations of PNE in predialysis patients
(35 4 ng/dl) were significantly higher (P < 0.01) than they
were in dialysis patients (24 3 ng/dl), controls (21 1 ng/dl)
and in those with chronic illness (21 3 ng/dl). Similarly, PE
levels in predialysis patients (3.3 0.6 ng/dl) were significantly
greater (P < 0.05) than they were in dialysis patients (2.1 0.4
ng/dI), controls (2.5 0.2 ng!dl) and in those with chronic
illness (2.1 0.4 ng/dl). PRA in predialysis (3.4 0.6 nglmL'hr)
and in dialysis patients (3.2 0.6 ng/ml/hr) was significantly
higher (P < 0.01) than in controls (1.3 0.1 nglml/hr) and in
patients with chronic illness (1.6 0.2 ng!mL/hr).
Urine sodium excretion during the 24 hr preceding the study
was 159 8 (range, 59 to 277 mEq/24 hr) in controls and 157
15 (range, 85 to 250 mEq/24 hr) in patients with chronic illness.
No systematic attempt was made to determine sodium excre-
tion in uremjc patients because of their renal failure.
There was a modest fall in the mean BP after standing and
ambulation in normal subjects and those with chronic illness,
but the change was significant only in the normal controls.
Dialysis patients did not have a decrease in BP during these
maneuvers. But, a marked and significant (P < 0.01) decrease
in the mean BP occurred in the predialysis patients; it fell by 15
4 and 15 3 mm Hg after 10 and 60 mm of ambulation,
respectively. The concentration of PNE increased significantly
in all four groups. But, the magnitude of rise in PNE after60 mm
of ambulation in the predialysis patients (60 7 ng/dl) was
significantly (P < 0.01) higher than that in normal subjects (28
2 ng/dl) dialysis patients (30 5 ng/dl) and those with
chronic illness (37 5 ngldl). The increments in heart rate after
orthostasis were not different among the four groups of sub-
jects. Both PE and PRA increased significantly with orthostasis
in all subjects and the magnitude of the increments were not
different among the four groups studied.
The effect of hemodialysis on mean BP, heart rate, PNE, PE
and PRA in 16 additional dialysis patients, studied in the supine
position, are shown in Table 2. There were no significant
changes in these parameters except for significant decrease in
body weight and in the plasma concentration of sodium and
potassium.
The changes in mean BP and heart rate during the NE
infusion in normal subjects, predialysis, and dialysis patients,
and in those with essential hypertension and normal renal
function are shown in Fig. 5. There was a dose-response
relationship between the changes in both mean BP and heart
rate and the amount of NE infused. In the predialysis patients,
the changes in mean BP with 20, 50, 100 ng/kg/min of NE were
—3.4 1.5, +4.2 2.6, and +13.2 2.9 mm Hg, values
significantly (P < 0.05) lower than those observed in normal
subjects (+2.3 1.9, + 11.4 2.7 and +23.0 4.7mm Hg) and
in those with essential hypertension and normal renal function
(+8.4 2.2, +17.3 1.7, +31.5 2.5mm Hg). The changes in
the latter groups were significantly (P < 0.01) greater than they
were in normal controls. The changes in mean BP in the dialysis
patients were (+3.8 1.1, +9.3 1.1, +17.0 1.5mm Hg),
not different than they were in normal subjects. Similarly, the
decrements in heart rate were significantly smaller (P < 0.05) in
the predialysis patients (—2.0 0.7, —3.2 2.2, and —4.4 3.3
beats/mm) than they were in dialysis patients (—3.0 2.4, —9.0
3.8, —13.0 4.3 beats/mm), normal subjects (—4.0 1.4,
—8.9 1.6, —12.0 1.8 beats/mm), and in those with essential
hypertension (—7.4 1.9, —12.2 2.0, —12.8 2.4beats/min).
There was no significant difference in the changes in heart rate
between the dialysis patients and normal subjects.
Discussion
Although dysfunctions in the autonomic nervous system
(ANS) have been previously reported in patients treated with
maintenance dialysis [3—8], similar abnormalities have not been
documented in patients prior to treatment with dialysis. Fur-
thermore, the mechanisms responsible for the dysfunction in
the ANS in uremia have not, as yet, been elucidated. We have
evaluated ANS function in predialysis and dialysis patients,
determined the blood levels of catecholamines, and examined
the reactivity of the target organs to norepinephrine (NE) in an
effort to understand the genesis and the pathways involved in
the derangement of the autonomic nervous function in uremia.
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Table 1. Mean blood pressure, heart rate, plasma levels of norepinephrine, epinephrine, and plasma renin activity during supine position, hand-
grip exercise, and orthostasisa
N
Age
yr
Mean blood pressure
mm Hg
Heart rate
beats/mm
Supine
Standing
Hand-grip
exercise 10 mm 50 mm Supine
Standing
Hand-grip
exercise 10 mm 50 mm
Normal subjects 60 35 1 81 1 109 2b 76 lb 76 lb 64 1 84 2b 85 2b 85 2b
Patients with
chronic illness
and normal renal
function 15 43 3 85 3 109 5b 82 4 81 4 67 2 80 2" 87 4b 89 4"
Predialysis
patients 21 40 3 100 4" 115 6" 84 5b.c 85 4b.a 80 3' 90 3" 98 4"" 100 4bc
Dialysis patients 16 38 3 95 3' 117 5" 94 5' 93 5" 79 3' 88 3" 98 4b.c 96 5b.c
One-way Anova NS <0.01 NS <0.01 <0.01 <0.01 NS <0.01 <0.01
a Data are presented as the means SEM.
b P < 0.01, compared with values in the supine position (Student's paired t test).
P < 0.01, compared with values in the normal subjects (by Tukey-HSD multiple comparisons).
Predialysis Dialysis
Fig. 3. Changes in mean blood pressure in normal subjects, in predialy-
sis and dialysis patients, and in patients with chronic illnesses but with
normal renal function in response to sustained hand-grip exercise at
one third of maximum voluntary contraction. The increment in mean
blood pressure was significantly lower (P < 0.01) in the two groups of
uremic patients. The brackets denote the mean SEM.
The results of our studies demonstrate that a large number of
predialysis and dialysis patients had dysfunction of ANS. These
included abnormal Valsalva ratio, abnormal response to hand-
grip tests, and abnormal fall in blood pressure (BP) during
orthostasis. The disturbances appear to be related to uremia
itself or to some of its consequences rather than to the state of
chronic illness, because patients with other chronic disease, but
normal renal function, did not have such abnormalities.
Two findings in our data indicate that some of these abnor-
malities are more extensive in the predialysis patients. First, the
abnormal response of blood pressure during the hand-grip
exercise was more frequent among the predialysis patients.
Second, the majority of the predialysis patients (67%) displayed
orthostatic hypotension whereas the response to upright pos-
ture in the dialysis patients was not different from normal
subjects.
-±-
AlA
Chronic
illness
FIg. 4. Changes in heart rate in normal subjects, in predialysis and
dialysis patients, and in patients with chronic illnesses but with normal
renal function in response to sustained hand-grip exercise at one third
of maximum voluntary contraction. The increment in heart rate was
significantly lower (P < 0.01) in the two groups of uremic patients. The
brackets denote mean SEM.
It is plausible that the anemia of uremia and the presence or
absence of hypertension may affect the function of the ANS.
Our data do not support either of these notions. First, the
abnormal Valsalva ratio and the abnormal response to hand-
grip exercise were not related to the magnitude of the anemia.
Second, many of the uremic patients had abnormal heart rate
response but normal BP response to hand-grip exercise. Third,
the response to orthostasis was abnormal in the predialysis
patients and normal in the dialysis patients despite no signifi-
cant difference in hematocrit. Finally, the abnormalities in the
function of ANS did not correlate with the presence or absence
of an elevated mean BP.
The abnormality in heart rate response during the Valsalva
maneuver was more pronounced during the release phase of the
test in both the predialysis and dialysis patients. During this
phase, an increase in systemic arterial pressure occurs, which is
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Table 1. (Continued)
Plasma norepinephrine
ng/dl
Plasma epinephrine
ngldl
Plasma renin activity
ag/mi/hr
Supine
Standing
Hand-gnp
exercise 10 mm 50 mm Supine
Standing
Hand-grip
exericse 10 mm 50 mm Supine
Standing
Hand-grip
exercise 10 mm 50 mm
21±1 29±2b 47±3b 48±2b 2.5±0.2 3.8±5b 4.4±0.4b4.9±0.4b 1.3±0.1 1.7±0.2" 2.0±0.3" 2.4±0.2"
21±3 24±3b 52±6b 57±7b 2.1±0.4 3.2±0.7" 4.2±0.7"5.3±1.1" 1.6±0.2 2.1±0.3" 2.6±0.4" 3.7±0.6b
35 4 42 5b.
24±3 29±3b
<0.01 <0.01
73 7.C 97 9b, 3.3 0.6c 4.2 0.7b 6.5 l.2b 7.1 1.1b, 3.4 0.6 3.9 0.6b. 4.1 0.6b,c 4.8 0.9b.
53 7b 55 5b 2.1 0.4 3.2 0.5b 4.0 1.0" 5.0 1.2" 3.2 0.6 4.2 0.7b.c 4.6 0.8b,c 50 1.Ob.c
<0.01 <0.01 <0.05 NS NS <0.05 <0.01 <0.01 <0.01 <0.01
Table 2. Effect ofa single hemodialysis on mean blood pressure, heart rate, plasma norepinephrine, epinephrine, plasma renin activity, body
weight, and plasma concentration of sodium and potassium in 16 patientsa
Mean BP
mm Hg
Heart rate
beats/mm
PNE
ng/di
PE
ng/dl
PRA
ag/mI/hr
Body wt
kg
5Na
mEqiliter
5K
mEq/liter
Before dialysis 101 4 73 4 25 5 7.9 2.0 4.0 1.2 69 4 137 1 5.3 0.1
After dialysis 98 4 81 4 27 4 6.3 1.0 6.6 2.5 67 3 133 1 3.9 0.1
P NS NS NS NS NS <0.01 <0.01 <0.01
Data are the means SEM. These patients are not among the patients included in Table 1. Abbreviations are defined as follows: BP, blood
pressure; F, plasma concentration; NE, norepinephrine; E, epinephrine; PRA, plasma renin activity; 5, serum concentration; Na, sodium; K,
potassium.
sensed by the baroreceptors in the aortic arch and carotid
arteries, subsequently leading to reflex bradycardia [13, 14].
The increase in BP is due to an increase in cardiac output
secondary to enhanced venous return and to increased periph-
eral vascular resistance produced by augmented sympathetic
tone [13—16]. The abnormal response in heart rate during the
release phase could be due to failure of the BP to rise secondary
to an inappropriate change in peripheral vascular resistance,
derangement in the vagal pathway, and/or disturbance in cardi-
ac function.
We did not use invasive techniques to monitor arterial
pressure during the Valsalva maneuver, but others have shown
that dialysis patients display a blunted arterial-pressure over-
shoot during the release phase of the test [7]. The more
pronounced abnormality in heart rate response during the
release phase of the Valsalva in the predialysis patients could
be, at least partially, due to a greater impairment in arterial
pressure response during this phase. This impairment could be
secondary to a resistance to the action of NE on blood vessels.
The demonstration in the dialysis patients that an elevation in
BP with the infusion of NE produced a normal fall in heart rate
suggests that the abnormal response in heart rate during the
release phase of the Valsalva maneuver may be due to a failure
of arterial pressure to rise in this phase of the test. It should be
emphasized, however, that abnormalities in the vagus pathways
could also be responsible for the abnormal response in heart
rate both in the predialysis and dialysis patients. Support for
this idea is found in the results of hand-grip test as discussed
below.
The hand-grip exercise is associated with an increase in heart
rate, cardiac output, and arterial pressure [18—20]. The pressor
response is believed to be mediated by cardiac acceleration
[18], but even when heart rate fails to increase during the test,
the pressor response occurs most probably due to increased
peripheral vascular resistance [201. Although the mechanisms
for these hemodynamic responses are not fully elucidated, a
participation of the sympathetic and parasympathetic nervous
systems has been proposed [18, 20]. Certain data suggest that
the change in heart rate is due to parasympathetic inhibition
(vagus release) [20], and that the increased peripheral resistance
is secondary to enhanced sympathetic activity [20]. The obser-
vation in our study that the majority of the patients who
displayed an abnormal response of heart rate during the hand-
grip exercise have also an abnormal Valsalva ratio is consistent
with the notion that a disturbance in the vagus pathways is
present in uremic patients. Furthermore, the demonstration
that 35% of the predialysis patients, but only 13% of the dialysis
patients, had abnormal pressor response (despite similar inci-
dence of deranged heart rate response) suggests that a distur-
bance in sympathetic activity is more predominant in the
predialysis patients. This proposal is consistent with the finding
of peripheral resistance to NE infusion in the predialysis
patients.
The maintenance of arterial pressure during orthostasis is
dependent on the ability to augment peripheral vascular resist-
ance [21, 22]. Our data clearly demonstrate that the majority of
the predialysis patients displayed marked postural hypotension(mean BP> 12 mm Hg), whereas the changes in BP were not
different from that in normal subjects in the dialysis patients.
The reason for this difference is most probably due to target-
organ resistance to NE present only in the predialysis patients.
Our data do not necessarily imply that orthostatic hypoten-
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Fig. 5. Changes in mean blood pressure and heart rate during norepi-
nephrine infusion at progressive doses of 20, 50, 100 ng/kg/min in JO
normal subjects, 5 of the predialysis, and 6 of the dialysis patients
included in Table I and in 10 patients with essential hypertension and
normal renal function. Each infusion rate was given for 10 mm. The
changes in mean blood pressure and heart rate were significantly (P <
0.01) lower in dialysis but not in predialysis patients, then in normal
subjects.
sion due to autonomic nerve dysfunction is not encountered in
dialysis patients but would suggest that such a problem is not
frequent. It is our opinion that if orthostatic hypotension is
noticed in a dialysis patient, a vigorous search for causes other
than uremic ANS dysfunction should be undertaken.
Our data do not provide information on the mechanism of the
resistance to the action of NE in the predialysis patients.
Because the resistance improves or disappears with dialysis
therapy it is tempting to speculate that dialyzable material is
responsible for the phenomenon. It is also possible that occupa-
tion and/or down regulation of the a-receptors of the vascular
smooth muscle due to elevated level of PNE plays a role in
decrease response to the agonist.
It is of interest that the blood levels of NE are elevated in the
predialysis patients and are normal in the dialysis subjects.
Atuck et a! [231 also found elevated blood levels of NE in
predialysis patients. The mechanisms for elevation in blood
levels of NE in uremia are not clear. Several factors could be
contributory, including decreased renal clearance, diminished
degradation secondary to reduced catechol-o-methyl transfer-
ase activity [23], reduced reuptake of the agonist from the
sympathetic neurons end-terminals [24], or increased release of
the hormone. The presence of resistance to the action of NE
results in hemodynamic consequences that would dictate an
increased need for the agonist and would result in the stimula-
tion of its release. The normalization of the blood levels of NE
in our dialysis patients is most probably secondary to an
improvement or a disappearance of the resistance to the action
of the hormone rather than to its loss during dialysis. Indeed,
our observation that blood levels of NE do not decrease during
the dialysis procedure is consistent with this postulate. Others
have also found that the dialysis procedure does not lower
blood levels of NE [25] whereas Lake et al [26] reported an
increase in these levels during dialysis.
The normal basal concentrations of PNE found in our dialysis
patients are in agreement with the results of Lake et a! [26] and
at variance with those of others [27—29]. The reasons for this
discrepancy are not obvious. It may be due to different method-
ology or to variable degrees in the improvement of the resist-
ance to the action of NE. This improvement may be influenced
by the efficacy of the dialysis treatment and its duration. Thus,
patients receiving inadequate dialysis or treated for shorter
periods of time may not have sufficient improvement in the
resistance to the action of the agonist and, thus, would still have
elevated levels of NE.
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